43 clinical trials matched your search for Breast Cancer. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Breast Cancer Study to Predict Your Therapeutic Response (I-SPY 2 Trial) Meghna Trivedi, MD
Breast Cancer Study Comparing Survival of Patients Monitored with Serum Tumor Marker Directed Disease Versus Usual Care in Metastatic Breast Cancer Melissa Accordino, MD
Breast Cancer Addinex-Opioid Dispenser for Post-Op Pain in Cancer Patients Dawn Hershman, MD
Breast Cancer MiChoice: Making Informed Choices on Incorporating Chemoprevention Into Care Katherine Crew, MD
Breast Cancer Study of Symptom Monitoring using Young, Empowered & Strong (YES) Web Portal for Breast Cancer Survivors Dawn Hershman, MD
Breast Cancer Study of Eribulin in Combination with Copanlisib in Patients with Metastatic Triple-Negative Breast Cancer Meghna Trivedi, MD
Breast Cancer Decreasing Chemotherapy for HER2 Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy Julia McGuinness, MD
Breast Cancer Study of T-DM1 in Combination with Tucatinib for Patients with HER2-Positive Breast Cancer Julia McGuinness, MD
Breast Cancer Intervention to Improve Medication Scheduling for Patients with Breast Cancer Dawn Hershman, MD
Breast Cancer Study of RLY-2608 in Patients with Breast Cancer Julia McGuinness, MD
Breast Cancer Study of Radiation Therapy Alone or in Combination With Olaparib for Patients with Inflammatory Breast Cancer (IBC) Eileen Connolly, MD, PhD
Breast Cancer Study of GLSI-100 in Female Patients with Breast Cancer Julia McGuinness, MD
Breast Cancer Study of Denosumab in Women with Breast Cancer who Carry the BRCA1 Mutation Katherine Crew, MD
Breast Cancer Study of Drug - LY3484356 in Patients with Breast Cancer (ER+, HER2-) Meghna Trivedi, MD
Breast Cancer Study of Sacituzumab Govitecan (TRODELVY) in Patients with Triple-Negative Breast Cancer (TNBC) Meghna Trivedi, MD
Breast Cancer Study of Sacituzumab Govitecan in Combination with Pembrolizumab vs. Chemotherapy in Patients with Advanced Triple-Negative Breast Cancer Meghna Trivedi, MD
Breast Cancer Study of Breast Cancer in Black Women Lauren Houghton, PhD
Breast Cancer Study of Breast Cancer in Black Women - Healthy Controls Lauren Houghton, PhD
Breast Cancer Tele-IPT vs. Tele-Pharmacotherapy for Depression in Patients with Non-Metastatic Breast Cancer John Markowitz, MD
Cancer Identification of Targets for Cancer Treatment Andrea Califano, PhD
Cancer Early Onset Malignancies Initiative (EOMI) Bret Taback, MD
Cancer TCR-engineered T Cells in Solid Tumors (ACTengine) Ran Reshef, MD
Cancer Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors Catherine Shu, MD
Cancer Study of IMC-F106C Alone and in Combination With Checkpoint Inhibitors in Participants with Advanced Cancers Benjamin Izar, MD
Cancer Study of Investigational Drug (RP-6306) in Patients with Advanced Cancer Ryan Moy, MD
Cancer Study of BAY 1895344 in Combination with Chemotherapy for Patients with Advanced Cancer Mark Stein, MD
Cancer Study of RP-3500 in Combination with PARP Inhibitor for Patients with Advanced Cancer Benjamin Herzberg, MD
Cancer Study of IDE397 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Depression Tele-IPT vs. Tele-Pharmacotherapy for Depression in Patients with Non-Metastatic Breast Cancer John Markowitz, MD
Cancer Study of CS5001 in Patients with Advanced Solid Tumors Shaheer Khan, DO
Cancer Study of BT7480 in Patients with Advanced Cancer Mark Stein, MD
Cancer Study of ASP3082 in Patients with Advanced Cancer with a KRAS G12D Mutation Benjamin Herzberg, MD
Cancer Study of 68Ga-FAP-2286 and 177Lu-FAP-2286 in Patients with Advanced Cancer Ryan Moy, MD
Cancer Study of E-602 Alone or in Combination with Libtayo (Cemiplimab) in Patients with Advanced Cancer Brian Henick, MD
Cancer Study of BLU-222 Alone or in Combination with Other Cancer Therapy for Patients with Advanced Cancer Brian Henick, MD
Cancer Study of LNS8801 Alone or in Combination with Pembrolizumab in Patients with Advanced Cancer Brian Henick, MD
Cancer Study of RMC-6291 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Lung Cancer Study of Patritumab Deruxtecan in Combination with Osimertinib in Patients with Non-Small Cell Lung Cancer (NSCLC) Catherine Shu, MD
Cancer Study of MRT-2359 in Patients with Solid Tumors Benjamin Herzberg, MD
Cancer Study of RMC-6236 in Patients with Solid Tumors with a KRAS Mutation Benjamin Herzberg, MD
Endocrine & Metabolic Disease Temporary Insulin Resistance Joshua Cook, MD, PhD
Diabetes Temporary Insulin Resistance Joshua Cook, MD, PhD
Healthy Volunteers Temporary Insulin Resistance Joshua Cook, MD, PhD
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE